Home   >  
Protease/Metabolic Enzyme
  • Protease/Metabolic Enzyme
HIV Protease

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

HIV Protease

Chemical Structure Cat. No. Product Name CAS No.
Pentosan Polysulfate Sodium Chemical Structure
BCP49204 Pentosan Polysulfate Sodium 140207-93-8
Pentosan Polysulfate Sodium is an orally bioavailable, semi-synthetic medication with anti-inflammatory and pro-chondrogenic properties. Pentosan Polysulfate Sodium also exhibits anti-HIV-1 activity.
Pitstop2 Chemical Structure
BCP48928 Pitstop2 1332879-52-3
Pitstop2 is an inhibitor of the interaction between the clathrin terminal domain and amphiphysin. It inhibits clathrin-mediated transferrin uptake and HIV-1 entry and infectivity reporter cell lines. It also inhibits clathrin-independent endocytosis of CD44, CD98, and CD147 in HeLa cells.
GS-CA-1 Chemical Structure
BCP44793 GS-CA-1 2189684-45-3
GS-CA1 is a potent HIV capsid inhibitor for HIV inhibition.
Brecanavir Chemical Structure
BCP44630 Brecanavir 313682-08-5
Brecanavir is a tyrosyl-based arylsulfonamide inhibitor of human immunodeficiency virus (HIV) protease.
TMC-310911 Chemical Structure
BCP44275 TMC-310911 1000287-05-7
TMC-310911 is an HIV protease inhibitor potentially for the treatment of HIV infection.
Acetylpepstatin Chemical Structure
BCP43342 Acetylpepstatin 28575-34-0
Acetyl Pepstatin is a high affinity aspartic protease inhibitor.
IMB-301 Chemical Structure
BCP40899 IMB-301 64009-84-3
IMB-301 is a small molecule inhibitor that target the binding interface of the HIV-1 Vif/hA3G complex, inhibits the replication of HIV-1 in H9 cells (IC50=8.63 uM).
Lenacapavir Chemical Structure
BCP40764 Lenacapavir 2189684-44-2
Lenacapavir, also known as GS-6207, is a HIV-1 capsid inhibitor.
PNU-103017 Chemical Structure
BCP36734 PNU-103017 166335-18-8
PNU-103017 is an HIV protease inhibitor.
JE-2147 Chemical Structure
BCP34046 JE-2147 186538-00-1
JE-2147 is a dipeptide HIV protease inhibitor (PI) that is effective against a wide spectrum of HIV-1, HIV-2, simian immunodeficiency virus, and various clinical HIV-1 strains in vitro.
123下一页共 29 条记录 1 / 3 页